Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis

Overview

Journal Cells

Publisher MDPI

Date 2025 Jan 10

PMID 39791706

Authors

Rasanpreet Kaur

Saurabh Gupta

Sunanda Kulshrestha

Vishal Khandelwal

Swadha Pandey

Anil Kumar

Gaurav Sharma

Umesh Kumar

Deepak Parashar

Kaushik Das

Affiliations

Soon will be listed here.

Abstract

Breast cancer is a cancer with global prevalence and a surge in the number of cases with each passing year. With the advancement in science and technology, significant progress has been achieved in the prevention and treatment of breast cancer to make ends meet. The scientific intradisciplinary subject of "metabolomics" examines every metabolite found in a cell, tissue, system, or organism from different sources of samples. In the case of breast cancer, little is known about the regulatory pathways that could be resolved through metabolic reprogramming. Evidence related to the significant changes taking place during the onset and prognosis of breast cancer can be obtained using metabolomics. Innovative metabolomics approaches identify metabolites that lead to the discovery of biomarkers for breast cancer therapy, diagnosis, and early detection. The use of diverse analytical methods and instruments for metabolomics includes Magnetic Resonance Spectroscopy, LC/MS, UPLC/MS, etc., which, along with their high-throughput analysis, give insights into the metabolites and the molecular pathways involved. For instance, metabolome research has led to the discovery of the glutamate-to-glutamate ratio and aerobic glycolysis as biomarkers in breast cancer. The present review comprehends the updates in metabolomic research and its processes that contribute to breast cancer prognosis and metastasis. The metabolome holds a future, and this review is an attempt to amalgamate the present relevant literature that might yield crucial insights for creating innovative therapeutic strategies aimed at addressing metastatic breast cancer.

References

Kingston B, Cutts R, Bye H, Beaney M, Walsh-Crestani G, Hrebien S . Genomic profile of advanced breast cancer in circulating tumour DNA. Nat Commun. 2021; 12(1):2423. PMC: 8065112. DOI: 10.1038/s41467-021-22605-2. View

Roig B, Rodriguez-Balada M, Samino S, Lam E, Guaita-Esteruelas S, Gomes A . Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer. Sci Rep. 2017; 7(1):17831. PMC: 5736621. DOI: 10.1038/s41598-017-17897-8. View

Mohr S, Perrimon N . RNAi screening: new approaches, understandings, and organisms. Wiley Interdiscip Rev RNA. 2011; 3(2):145-58. PMC: 3249004. DOI: 10.1002/wrna.110. View

Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

Holsbo E, Olsen K . Metastatic Breast Cancer and Pre-Diagnostic Blood Gene Expression Profiles-The Norwegian Women and Cancer (NOWAC) Post-Genome Cohort. Front Oncol. 2020; 10:575461. PMC: 7594625. DOI: 10.3389/fonc.2020.575461. View

Hasin Y, Seldin M, Lusis A . Multi-omics approaches to disease. Genome Biol. 2017; 18(1):83. PMC: 5418815. DOI: 10.1186/s13059-017-1215-1. View

Beretov J, Wasinger V, Millar E, Schwartz P, Graham P, Li Y . Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach. PLoS One. 2015; 10(11):e0141876. PMC: 4636393. DOI: 10.1371/journal.pone.0141876. View

Dang C, Le A, Gao P . MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009; 15(21):6479-83. PMC: 2783410. DOI: 10.1158/1078-0432.CCR-09-0889. View

Silva J, Silva J, Sanchez A, Garcia J, Dominguez G, Provencio M . Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival. Clin Cancer Res. 2002; 8(12):3761-6. View

10.

Chang C, Qiu J, OSullivan D, Buck M, Noguchi T, Curtis J . Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015; 162(6):1229-41. PMC: 4864363. DOI: 10.1016/j.cell.2015.08.016. View

11.

Patra K, Hay N . The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014; 39(8):347-54. PMC: 4329227. DOI: 10.1016/j.tibs.2014.06.005. View

12.

Joshi S, Garlapati C, Bhattarai S, Su Y, Rios-Colon L, Deep G . Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer. Int J Mol Sci. 2022; 23(10). PMC: 9141543. DOI: 10.3390/ijms23105324. View

13.

Jiao L, Zhang H, Li D, Yang K, Tang J, Li X . Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy. 2017; 14(4):671-684. PMC: 5959330. DOI: 10.1080/15548627.2017.1381804. View

14.

Budczies J, Pfitzner B, Gyorffy B, Winzer K, Radke C, Dietel M . Glutamate enrichment as new diagnostic opportunity in breast cancer. Int J Cancer. 2014; 136(7):1619-28. DOI: 10.1002/ijc.29152. View

15.

Paul A, Paul S . The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed). 2014; 19(4):605-18. PMC: 4307936. DOI: 10.2741/4230. View

16.

Liu J, Zhang C, Hu W, Feng Z . Tumor suppressor p53 and its mutants in cancer metabolism. Cancer Lett. 2013; 356(2 Pt A):197-203. PMC: 4069248. DOI: 10.1016/j.canlet.2013.12.025. View

17.

Wilde L, Roche M, Domingo-Vidal M, Tanson K, Philp N, Curry J . Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. Semin Oncol. 2017; 44(3):198-203. PMC: 5737780. DOI: 10.1053/j.seminoncol.2017.10.004. View

18.

M Maria R, Altei W, Selistre-de-Araujo H, Colnago L . Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using H HR-MAS NMR spectroscopy. J Pharm Biomed Anal. 2017; 146:324-328. DOI: 10.1016/j.jpba.2017.08.038. View

19.

Wang Y, Liu F, Sun L, Jia Y, Yang P, Guo D . Association between human blood metabolome and the risk of breast cancer. Breast Cancer Res. 2023; 25(1):9. PMC: 9872401. DOI: 10.1186/s13058-023-01609-4. View

20.

Kim S, Kim D, Jung W, Koo J . Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. Endocr Relat Cancer. 2013; 20(3):339-48. DOI: 10.1530/ERC-12-0398. View